Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900003 · ClinicalTrials.gov registry record
Studying Biomarkers in Patients With Pancreatic Cancer
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- 53
- Enrollment target
NCT00900003 is a clinical trial that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 53 participants.
The verdict
NCT00900003 has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tissue in the laboratory from patients with cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is studying biomarkers in patients with pancreatic cancer.
Interventions
- OTHER laboratory biomarker analysis
- GENETIC protein analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2007-05 |
| Est. Completion | 2013-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00900003
The ClinicalTrials.gov registry entry for NCT00900003 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT00900003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00900003 about?
NCT00900003 is a clinical study titled "Studying Biomarkers in Patients With Pancreatic Cancer". RATIONALE: Studying samples of tissue in the laboratory from patients with cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is studying biomarkers in patients wit...
What is the current status of trial NCT00900003?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2007-05. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00900003?
The interventions under investigation include: laboratory biomarker analysis (OTHER), protein analysis (GENETIC).
Who is sponsoring clinical trial NCT00900003?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.